The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.675
Bid: 0.65
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.05 (7.692%)
Open: 0.675
High: 0.675
Low: 0.675
Prev. Close: 0.675
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: NHS Uses Induction Healthcare's Mobile App

Thu, 16th Apr 2020 14:57

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Thursday and late Wednesday and not separately reported by Alliance News:

----------

Induction Healthcare Group PLC - healthcare technology - Says majority of doctors in UK National Health Service using Induction healthcare information mobile application. Says demand for company's tools have increased as a result of Covid-19 outbreak.

----------

N4 Pharma PLC - pharmaceuticals - Receives Covid-19 plasmid DNA from National Institute for Health in US. Researching whether Nuvec medication can produce Covid-19 antibodies.

----------

Target Healthcare REIT PLC - healthcare property investor - Received rent collection for March quarter in line with usual collection patterns. Says confirmed Covid-19 cases affecting fewer than 5% of beds in its portfolio.

----------

Two Shields Investments PLC - investor - Portfolio company BrandShield warns of increase in phishing scams during the pandemic. Warns that illicit scams target users of streaming services, 639 new domain names with the word Netflix were registered since beginning of 2020.

----------

Morses Club PLC - lender - Launches remote lending product. Says 33% of collections transferred from face-to-face to remote over past three weeks.

----------

Charles Stanley Group PLC - wealth manager - Funds under management down 20% to GBP20.2 billion in three months to March from GBP25.3 billion in December amid market volatility.

----------

Management Consulting Group PLC - consultants - Says 2020 started promisingly but trading began to suffer in Asia in February due to pandemic. Disruption spread to other regions in March. Targeting, unconnected to Covid-19, GBP4 million in annual cost savings.

----------

Dillistone Group PLC - recruitment software - Had "strong" start to 2020 prior to Covid-19 impact. Says demand suffered due to pandemic. Says no full-year guidance and delays annual results, initially penned to be reported on April 27.

----------

Gaming Realms PLC - mobile games - Delays full-year results that were initially planned for this week. Audit yet to be completed due to Covid-19 disruption.

----------

Sportech PLC - gambling software - Delays annual general meeting due to Covid-19. AGM to be held before end of June, but not on May 20 as initially planned. Chair and chief executive officer take 50% pay cuts, salary freeze implemented, and "significant" number of staff furloughed.

----------

Escape Hunt PLC - escape room experiences - Has furloughed 124 staff and expects VAT and other tax deferrals. Says some landlords have allowed for rent payments to be deferred and senior staff have taken 25% pay cut. Company's monthly cash costs slashed by 70%.

----------

Revolution Bars Group PLC - bar operator - Increases Natwest revolving credit facility to GBP30.0 million until August 31.

----------

Hornby PLC - toys and hobby products - Benefiting from government support schemes in markets where it operates. Says full-year revenue and gross margin ahead of year prior but no financial guidance of Covid-19 impact due to uncertainty.

----------

Walker Greenbank PLC - interior furnishings - Closed factories in UK as well as showrooms elsewhere in New York and Paris. Accessing government support schemes "wherever possible". Vast majority of employees furloughed and management team take 20% salary reduction.

----------

Haydale Graphene Industries PLC - advanced materials - Still assessing full impact of virus but notes falling demand for silicon carbide blanks. Taking advantage of US and UK government support schemes.

----------

Woodbois Ltd - forestry and timber - Says first quarter revenue up 10% year-on-year amid no Covid-19 demand hit until end of quarter. Factories in Gabon closed due to lockdown.

----------

DX Group PLC - freight and delivery - Says delivery activity down by 33% immediately after UK government lockdown. Furloughs some employees and has cut spending.

----------

Volex PLC - power products - Sales for the year ended April 5 up 5.4% to USD392 million from USD372 million. Expects future trading to be hit by government containment measures due to Covid-19.

----------

Proton Motor Power Systems PLC - fuel cell technology - No case of Covid-19 at factories. Protective measures in place at Puchheim, Munich unit.

----------

Amedeo Air Four Plus Ltd - aircraft leasing - Customer Emirates seeking financial accommodation. Amedeo asks asset manager to continue talks with the airline and its lending banks.

----------

TP Group PLC - engineering services - To build gas production equipment in response to Covid-19. Says equipment will be able to produce medical gases.

----------

Kodal Minerals PLC - exploration and development - Granted renewal of exploration permits at Dabakala and Korhogo gold projects in Cote d'Ivoire. Notes planned activity at joint-venture projects with Resolute Mining Ltd postponed due to virus.

----------

SolGold PLC - gold and copper miner - Receives expressions of interest for potential concentrate offtake at Alapala project, Ecuador. Says 10 received and more expected when Covid-19 restrcitions lifted.

----------

Hummingbird Resources PLC - gold miner - No material production hit from Covid-19 but risk mitigation measures in place. First quarter production down 11% quarter-on-quarter to 30,282 ounces of gold poured.

----------

Capital Drilling Ltd - mining services - Says mining operations continue uninterrupted despite Covid-19 uncertainty. Supply chain movement mainly land and sea based so largely unaffected by travel curbs. First-quarter revenue rises 20% to USD32.5 million.

----------

Base Resources Ltd - mineral explorers - Says operations at Kwale, Kenya continued uninterrupted so full-year guidance maintained. In quarter-ended March, ilmenite production up 20% year-on-year, rutile up 17% and zircon rises 32%.

----------

Reabold Resources PLC - oil project investor - Drilling at IMIC-2 well in 50%-owned Danube project, Romania delayed due to Covid-19 border closures. Reports commencement of activity at West Newton B site onshore UK.

----------

Tlou Energy Ltd - gas and solar projects - Says cost reductions in place to counter Covid-19 impact. Notes state of national emergency declared in Botswana.

----------

Great Western Mining Corp PLC - explorer - Application for surface disturbance works at Nevada acreage accepted in "timely manner" despite Covid-19 outbreak.

----------

Anglo Asian Mining PLC - gold, silver and copper producer - Reports 10% first quarter fall in gold equivalent production to 18,219 ounces. Says first quarter in line with guidance despite Covid-19 outbreak.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
14 Sep 2020 10:52

N4 Pharma Plunges 40% As Covid-19 Antibody Delivery Study Disappoints

N4 Pharma Plunges 40% As Covid-19 Antibody Delivery Study Disappoints

Read more
14 Sep 2020 09:04

N4 Pharma plunges as Covid-19 progress stalls

(Sharecast News) - N4 Pharma lost more than a third of its value after the company said its potential Covid-19 vaccine delivery method did not produce a positive result at stage 3 of tests.

Read more
1 Sep 2020 21:35

IN BRIEF: N4 Pharma Signs Technology Transfer & Manufacturing Contract

IN BRIEF: N4 Pharma Signs Technology Transfer & Manufacturing Contract

Read more
1 Sep 2020 09:19

N4 Pharma chooses Ardena as contract manufacturing partner

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has appointed the API and nanomedicines business unit of Ardena as its contract development and manufacturing organisation partner for the technology transfer and upscaling manufacture of 'Nuvec', it announced on Tuesday.

Read more
12 Aug 2020 14:18

N4 Pharma Shares Spike 30% On Successful Covid-19 Study

N4 Pharma Shares Spike 30% On Successful Covid-19 Study

Read more
6 Jul 2020 14:13

IN BRIEF: N4 Pharma's Nuvec Shows Promise In Oral Vaccine Delivery

IN BRIEF: N4 Pharma's Nuvec Shows Promise In Oral Vaccine Delivery

Read more
28 May 2020 14:49

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

Read more
28 May 2020 09:47

N4 Pharma completes first stage proof of concept work for Nuvec

(Sharecast News) - Pharmaceutical group N4 Pharma has completed the first phase of Covid-19 proof of concept work for Nuvec, the group's novel delivery system for cancer treatments and vaccines.

Read more
18 May 2020 15:39

N4 Pharma To File Nuvec Patent Across Europe, US, Other Major Markets

N4 Pharma To File Nuvec Patent Across Europe, US, Other Major Markets

Read more
13 May 2020 14:55

N4 Pharma Raises GBP2 Million To Fund Covid-19 Research Project

N4 Pharma Raises GBP2 Million To Fund Covid-19 Research Project

Read more
13 May 2020 11:30

N4 Pharma raises ?2.03m via oversubscribed placing

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has raised ?2.03m through an oversubscribed placing of 50,731,250 new ordinary shares, it announced on Wednesday, at a price of 4p each.

Read more
24 Apr 2020 14:33

N4 Pharma Files Patent For Nuvec Opportunities In Viral Vector Market

N4 Pharma Files Patent For Nuvec Opportunities In Viral Vector Market

Read more
24 Apr 2020 09:30

N4 Pharma files for new UK patent on 'Nuvec'

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has filed a new UK patent application around both the ability of its 'Nuvec' delivery system ability to be used to manufacture viral vectors, and to make viral vectors more efficient in applications such as ex-vivo gene therapy treatments.

Read more
16 Apr 2020 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.